Company news

Ion Beam Applications SA news in 2026

Ion Beam Applications SA's news releases, calls and decks from 2026, newest first.

View company

IBA selected to support the US expansion of a leading radiopharmaceutical producer with an order for 12 Cyclone® KIUBE systems

October 15, 2026

IBA and Telix strengthen ties through agreement to distribute ARTMS’s QIS®

October 1, 2026

IBA signs contract to install the first proton therapy center in central Italy, in Rome

September 29, 2026

IBA Launches QUASAR® Penta-Guide Performance Phantom

September 27, 2026

IBA joins PFAROS European initiative to advance PFAS destruction for healthcare and pharmaceutical applications

September 2, 2026

IBA reports Half Year 2026 results, on track with its improved profitability trajectory

August 27, 2026

IBA Notice of Half Year 2026 Results and Conference Call

August 6, 2026

IBA to install the first proton therapy center in Brazil in Rio de Janeiro

June 25, 2026

IBA strengthens its Board with two high-profile appointments and announces the payment date of its dividend

June 17, 2026

IBA strengthens its leadership team to support its growth

June 17, 2026

IBA Announces Research Collaboration to Strengthen Evidence on the Value of Proton Therapy

June 10, 2026

IBA signs contract with a major U.S. academic medical center to install two Proteus®ONE proton therapy solutions

June 8, 2026

IBA launches Cyclone® iKure, a cyclotron designed for industrial scale Astatine-211 production

June 1, 2026

First quarter 2026 update: starting the year on track, with product innovation progress

May 21, 2026

IBA launches Rhodotron® LITE, a new low‑power X‑ray accelerator expanding access to sustainable irradiation solutions

May 20, 2026

IBA introduces AdaPTinsight XR, the next generation of CBCT imaging for image-guided proton therapy

May 13, 2026

IBA Introduces myQA StarTrack³ for Fast, High Resolution Linac QA with a Single Detector Setup

May 6, 2026

IBA – acquisition of own shares

April 27, 2026

IBA delivers strong FY 2025 results with solid execution in all segments

March 27, 2026

IBA Launches myQAMatriXXAiR to Advance Patient‑Specific QA in Particle Therapy

March 21, 2026

Telix selects IBA Cyclone® KIUBE to support manufacturing expansion in the U.S.

March 20, 2026

IBA Notice of Full Year 2025 Results and Conference Call

March 13, 2026

IBA – transparency notification

February 25, 2026

IBA and Shreeji sign multi‑site agreement for four cyclotrons to expand PET radiopharmaceutical manufacturing across India

February 19, 2026

IBA – Share buyback

February 2, 2026

IBA signs contract for a Proteus®ONE proton therapy system to be located at the MacKay Memorial Hospital in New Taipei City, Taiwan

January 27, 2026

IBA selected by MD Anderson Cancer Center to supply three Proteus®ONE systems

January 19, 2026

Calls in 2026

Decks in 2026